Insulet Corporation (PODD) is a publicly traded Healthcare sector company. As of July 7, 2026, PODD trades at $163.30 with a market cap of $11.07B and a P/E ratio of 37.60. PODD moved +1.08% today. Year to date, PODD is -43.72%; over the trailing twelve months it is -46.28%. Its 52-week range spans $138.79 to $354.88. Analyst consensus is strong buy with an average price target of $227.48. Rallies surfaces PODD's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for PODD, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $163.30 |
| Market Cap | $11.07B |
| P/E Ratio | 37.60 |
| EPS | $4.30 |
| Dividend Yield | 0.00% |
| 52-Week High | $354.88 |
| 52-Week Low | $138.79 |
| Volume | 518.50K |
| Avg Volume | 0 |
| Revenue (TTM) | $2.90B |
| Net Income | $302.80M |
| Gross Margin | 71.01% |
22 analysts cover PODD: 0 strong buy, 18 buy, 3 hold, 1 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $227.48.